Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis

Blood

Volumn 101, Issue 11, 2003, Pages 4298-4300

  Mundschau, Gina ^b   Gurbuxani, Sandeep ^b   Gamis, Alan S ^b   Greene, Marianne E ^b   Arceci, Robert J ^b   Crispino, John D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 1; DNA BINDING PROTEIN; ERYTHROID SPECIFIC DNA BINDING FACTOR; GATA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DOWN SYNDROME; FEMALE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LEUKEMOGENESIS; MALE; MUTAGENESIS; MYELOPROLIFERATIVE DISORDER; NEWBORN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ACUTE NONLYMPHOCYTIC LEUKEMIA; CELL TRANSFORMATION; GENETICS; NUCLEOTIDE SEQUENCE;

CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; DOWN SYNDROME; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; INFANT, NEWBORN; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MUTAGENESIS; MYELOPROLIFERATIVE DISORDERS; TRANSCRIPTION FACTORS;

EID: 0038142390     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3904     Document Type: Article

References (10)

1. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol. 2000;110:512-524
2. Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24:2-5.
3. Taub JW, Ravindranath Y. Down syndrome and the transient myeloproliferative disorder: why is it transient? J Pediatr Hematol Oncol. 2002;24:6-8.
4. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148-152.
5. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266-270.
6. Freson K, Devriendt K, Matthiis G, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 2001;98:85-92.
7. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 2001;98:2681-2688.
8. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100:2040-2045.
9. Malkin D, Brown EJ, Zipursky A. The role of p53 in megakaryocytic differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genet Cytogenet. 2000;116:1-5.
10. Downing J, Shannon K. Acute leukemia: a pediatric perspective. Cancer Cell. 2002;2:437-445.